Loading memory…
Loading memory…
Patent portfolio assigned to Digistain (verified via public assignee records). Estimated patent count: 3. Digistain (digistain.co.uk), UK, infrared-spectroscopy breast-cancer biomarker diagnostic spun out of Imperial College. Patents confirmed: US11313792B2 and US20220178820A1 ('Method for observing a sample in the infrared range'), plus WO2016174441A1 ('Infrared imaging of biological material'); count ~3 visible (approx). No named customers (clinical/diagnostics, early); no clean direct-competitor list sourced (genomic-test incumbents not confirmed as named competitors this task).